DNP 810 Topic 4 DQ 1 Describe one genetic test and its impact on health prevention screening diagnostics treatment selection and treatment effectiveness

Grand Canyon University DNP 810 Topic 4 DQ 1 Describe one genetic test and its impact on health prevention screening diagnostics treatment selection and treatment effectiveness-Step-By-Step Guide

This guide will demonstrate how to complete the Grand Canyon University DNP 810 Topic 4 DQ 1 Describe one genetic test and its impact on health prevention screening diagnostics treatment selection and treatment effectiveness assignment based on general principles of academic writing. Here, we will show you the A, B, Cs of completing an academic paper, irrespective of the instructions. After guiding you through what to do, the guide will leave one or two sample essays at the end to highlight the various sections discussed below.

How to Research and Prepare for DNP 810 Topic 4 DQ 1 Describe one genetic test and its impact on health prevention screening diagnostics treatment selection and treatment effectiveness                       

Whether one passes or fails an academic assignment such as the Grand Canyon University DNP 810 Topic 4 DQ 1 Describe one genetic test and its impact on health prevention screening diagnostics treatment selection and treatment effectiveness depends on the preparation done beforehand. The first thing to do once you receive an assignment is to quickly skim through the requirements. Once that is done, start going through the instructions one by one to clearly understand what the instructor wants. The most important thing here is to understand the required format—whether it is APA, MLA, Chicago, etc.

After understanding the requirements of the paper, the next phase is to gather relevant materials. The first place to start the research process is the weekly resources. Go through the resources provided in the instructions to determine which ones fit the assignment. After reviewing the provided resources, use the university library to search for additional resources. After gathering sufficient and necessary resources, you are now ready to start drafting your paper.

How to Write the Introduction for DNP 810 Topic 4 DQ 1 Describe one genetic test and its impact on health prevention screening diagnostics treatment selection and treatment effectiveness                       

The introduction for the Grand Canyon University DNP 810 Topic 4 DQ 1 Describe one genetic test and its impact on health prevention screening diagnostics treatment selection and treatment effectiveness is where you tell the instructor what your paper will encompass. In three to four statements, highlight the important points that will form the basis of your paper. Here, you can include statistics to show the importance of the topic you will be discussing. At the end of the introduction, write a clear purpose statement outlining what exactly will be contained in the paper. This statement will start with “The purpose of this paper…” and then proceed to outline the various sections of the instructions.

How to Write the Body for DNP 810 Topic 4 DQ 1 Describe one genetic test and its impact on health prevention screening diagnostics treatment selection and treatment effectiveness                       

After the introduction, move into the main part of the DNP 810 Topic 4 DQ 1 Describe one genetic test and its impact on health prevention screening diagnostics treatment selection and treatment effectiveness  assignment, which is the body. Given that the paper you will be writing is not experimental, the way you organize the headings and subheadings of your paper is critically important. In some cases, you might have to use more subheadings to properly organize the assignment. The organization will depend on the rubric provided. Carefully examine the rubric, as it will contain all the detailed requirements of the assignment. Sometimes, the rubric will have information that the normal instructions lack.

Another important factor to consider at this point is how to do citations. In-text citations are fundamental as they support the arguments and points you make in the paper. At this point, the resources gathered at the beginning will come in handy. Integrating the ideas of the authors with your own will ensure that you produce a comprehensive paper. Also, follow the given citation format. In most cases, APA 7 is the preferred format for nursing assignments.

How to Write the Conclusion for DNP 810 Topic 4 DQ 1 Describe one genetic test and its impact on health prevention screening diagnostics treatment selection and treatment effectiveness                       

After completing the main sections, write the conclusion of your paper. The conclusion is a summary of the main points you made in your paper. However, you need to rewrite the points and not simply copy and paste them. By restating the points from each subheading, you will provide a nuanced overview of the assignment to the reader.

How to Format the References List for DNP 810 Topic 4 DQ 1 Describe one genetic test and its impact on health prevention screening diagnostics treatment selection and treatment effectiveness                       

The very last part of your paper involves listing the sources used in your paper. These sources should be listed in alphabetical order and double-spaced. Additionally, use a hanging indent for each source that appears in this list. Lastly, only the sources cited within the body of the paper should appear here.

Stuck? Let Us Help You

Completing assignments can sometimes be overwhelming, especially with the multitude of academic and personal responsibilities you may have. If you find yourself stuck or unsure at any point in the process, don’t hesitate to reach out for professional assistance. Our assignment writing services are designed to help you achieve your academic goals with ease. 

Our team of experienced writers is well-versed in academic writing and familiar with the specific requirements of the DNP 810 Topic 4 DQ 1 Describe one genetic test and its impact on health prevention screening diagnostics treatment selection and treatment effectiveness assignment. We can provide you with personalized support, ensuring your assignment is well-researched, properly formatted, and thoroughly edited. Get a feel of the quality we guarantee – ORDER NOW. 

Sample Answer for DNP 810 Topic 4 DQ 1 Describe one genetic test and its impact on health prevention screening diagnostics treatment selection and treatment effectiveness Included After Question

In the past decade there have been many advances in genetics and genomics and their application to health screening, diagnosis, treatment, and prognosis. What recent advancement do you believe is the most significant for your clinical practice? Explain. Support your rationale with a minimum of two scholarly sources.

A Sample Answer For the Assignment: DNP 810 Topic 4 DQ 1 Describe one genetic test and its impact on health prevention screening diagnostics treatment selection and treatment effectiveness

Title:  DNP 810 Topic 4 DQ 1 Describe one genetic test and its impact on health prevention screening diagnostics treatment selection and treatment effectiveness

An advancement that I consider the most significant in my clinical practice is recombinant DNA technology. It has played an important role in improving population health through the development of pharmaceuticals and new vaccines. It also adds to the management strategies in the home health setting through the development of diagnostic kits, monitoring devices, and new approaches in therapy (Horton & Lucassen, 2019).The technology revolutionized home health practice and provided new opportunities for the production of a broad range of therapeutic products that play a great role against lethal human diseases. According to Aggarwal (2021), the most recognized forms of therapy include; vaccines, insulin, human growth hormones, and antibiotics such as penicillin’s. For instance, in the home health setting, insulin, a therapeutic agent, plays a huge role in the management of type 1 DM, and to increase sensitivity of pancreatic cells to metformin in patients with type 2 DM, for better glycemic control. 

Using the same technology, scientists have developed and combined vectors for genetic modification and gene therapy. In gene therapy, scientists make site-specific modifications to a single genome with the intent of correcting an altered (mutated) gene or to make modifications that are specific to a site and target therapeutic management (Horton & Lucassen, 2019).The approach to gene therapy is wide with the potential for managing illnesses that occur as a result of recessive gene disorders. The most significant diseases in this category include; sickle cell anemia, cystic fibrosis, hemophilia, and muscular dystrophy, for which we closely monitor and follow-up patient in the home health setting. Aggarwal (2021) highlights that presently, there is ongoing research for different forms of gene therapy to replace maladaptive and defective genes that are associated with monogenic diseases such as sickle cell anemia and cystic fibrosis, to alter or kill aberrant cancer and HIV cells, and in the management of hepatitis C, to induce the production of therapeutic proteins.

References

Aggarwal, S. (2021). Biotechnology Applications In Medicine. International Journal of Social Science and Economic Research, 6(10).

Horton, R. H., & Lucassen, A. M. (2019). Recent developments in genetic/genomic medicine. Clinical Science, 133(5), 697-708. Doi: 10.1042/CS20180436. PMID: 30837331; PMCID: PMC6399103.

A Sample Answer 2 For the Assignment: DNP 810 Topic 4 DQ 1 Describe one genetic test and its impact on health prevention screening diagnostics treatment selection and treatment effectiveness

Title:  DNP 810 Topic 4 DQ 1 Describe one genetic test and its impact on health prevention screening diagnostics treatment selection and treatment effectiveness

There has been an extraordinary medical advancement in the knowledge of the human genome and its role in health and disease. Making sense of genomic data requires computational technologies and databases to evolve parallel with sequencing technologies. Both technologies enable an ever-increasing capacity for accurately diagnosing existing diseases and developing effective and targeted treatment strategies (Logsdon et al., 2020). In addition, genomic analysis provides opportunities for new approaches to therapeutic development, health care delivery, and population health management (Logsdon et al., 2020). The medical and scientific communities worldwide are just starting to seize the transformative opportunities that personalized, precision genomic medicine offers.

A monumental medical breakthrough has been the ability to sequence the DNA in cancer cells. The sequence can be compared to the arrangement found by the Human Genome Project  (Gibbs, 2020). This allows scientists to determine which genes are mutated, giving them ideas for developing medicines (Gibbs, 2020). Genome-wide sequencing is also being applied to the analysis of circulating DNA in the plasma of cancer patients and individuals with other diseases (Siegel et al., 2018). DNA sequencing involves the patients’ tumor tissue being scanned for hundreds of mutations or other abnormalities linked to cancer (Siegel et al., 2018). These specific scanning outcomes can prove indicative for patients who provide eligibility for clinical trials capitalizing upon targeted therapeutics which can pave the way for potential new treatments, which are currently undertaking examinations.

In addition, DNA sequencing can also undergo employment for the appropriate determination of patients at potential risk of cancers passed down by means of inheritance. For instance, cellular identification of mutations occurring within either the BRCA@ or BRCA1 gene serves as indicative when concerning an individual’s probability of developing cancers associated with those mutations (Siegel et al., 2018). If so, there are a variety of measures such individuals can take to reduce their risk. The strengths of this technology enable non-invasive tumor detection and monitoring responses to therapy that promises to significantly improve patient management (Siegel et al., 2018). To further illustrate, the abilities provided by genomic sequencing broaden the potential in the works for both therapies as well as diagnostics (Siegel et al., 2018).

References 

Gibbs, R. A. (2020). The human genome project changed everything. Nature Reviews Genetics, 21(10), 575-576.

Logsdon, G. A., Vollger, M. R., & Eichler, E. E. (2020). Long-read human genome sequencing and its applications. Nature Reviews Genetics, 21(10), 597-614.

Siegel, M. B., He, X., Hoadley, K. A., Hoyle, A., Pearce, J. B., Garrett, A. L., … & Perou, C. M. (2018). Integrated RNA and DNA sequencing reveal early drivers of metastatic breast cancer. The Journal of clinical investigation, 128(4), 1371-1383.

A Sample Answer 3 For the Assignment: DNP 810 Topic 4 DQ 1 Describe one genetic test and its impact on health prevention screening diagnostics treatment selection and treatment effectiveness

Title:  DNP 810 Topic 4 DQ 1 Describe one genetic test and its impact on health prevention screening diagnostics treatment selection and treatment effectiveness

Understanding the human genome and sequencing has opened the door to many healthcare advances. Screening and prevention can be targeted to at-risk groups based on inherited genes, traits, and susceptibilities. Additionally, using genetic information, medications and treatments can be targeted to specific groups based on genomic information. Much of this information, however, has been obtained from people of European descent, thus leaving minority groups out (Henderson et al., 2018). American Indians are an underrepresented group as it relates to studying disease, effective treatments, and pharmacogenetics. Without being included in the studies for precision medicine, this group may not see the benefit and have treatments or medications tailored to their unique genetic make-up. Using the concept of precision medicine avoids the cookie-cutter approach to disease management. Rather, this type of medicine focuses on genetic makeup, environment, and lifestyle.

The advancement of applying genetic information, especially as it relates to unique individual genetics is a remarkable advancement. Working in an ICU, many patients tend to display acute effects of long-term diseases. When left untreated or undertreated, chronic diseases, such as diabetes mellitus, can damage other organs, such as kidneys, vascular system, or the heart.  With three American Indian reservations being served by the institution I work at; the critical care unit tends to see a disproportionate number of American Indians compared to those of other descents. Commonly, the complications being experienced by this collective group is due to uncontrolled diabetes. Often it is due to renal failure, peripheral vascular disease, or coronary artery disease. Compared to Non-Hispanic whites, American Indians and Alaska Natives are 2.3 times more likely to die from diabetes (US Department of Health and Human Services Office of Minority Health, 2021). While there is still work being conducted on diabetes and American Indians and Alaska Natives, there are known genes that explain the genetic predilection for diabetes, such as cHOMA-B and GCK (Balakrishnan et al., 2018).  While there is still research being conducted on the genetic connection of diabetes, this is an area of hope to reduce the effects of this disease with targeted interventions and medications based on specific genetic makeup.

References

Balakrishnan, P., Vaidya, D., Voruganti, V. S., Haack, K., Kent, J. W., North, K. E., Laston, S., Howard, B. V., Umans, J. G., Lee, E. T., Best, L. G., MacCluer, J. W., Cole, S. A., Navas-Acien, A. & Franceschini, N. (2018). Genetic variants related to cardiometabolic traits are associated to B cell function, insulin resistance, and diabetes among AmeriCan Indians: the strong heart family study. Frontiers in Genetics, 9. Doi: 10.3389/fgene.2018.00466

Henderson, L. M., Claw, K. G., Woodahl, E. L., Robinson, R. F., Boyer, B. B., Burke, W., Thummel, K. E. (2018). P450 pharmacogenetics in indigenous North American Populations. Journal of Personalized Medicine, 8(1), 9. Doi: 10.2290/jpm8010009.

US Department of Health and Human Services Office of Minority Health. (2021, March 1st). Diabetes and American Indians/Alaska Natives. https://minorityhealth.hhs.gov/omh/browse.aspx?lvl=4&lvlid=33.